ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Is Axon Stock Too Expensive—or Just Getting Started?

London, UK. 19th July 2023. Body camera being worn by police officers in London, to keep officers safe, enabling situation awareness, improving community relations and providing evidence for trials. — Stock Editorial Photography

For security and defense company Axon Enterprise (NASDAQ: AXON), Q1 earnings were exactly what it needed to take its 2025 returns from decent to delightful.

[content-module:CompanyOverview|NASDAQ: AXON]

The company’s results massively impressed markets, leading to shares rising over 14% afterwards. The broadly positive effects of the United States and China trade deal also boosted Axon shares.

Combining these moves, Axon shares are now up approximately 22% in 2025 as of the May 13 close. Just prior to the earnings release, shares were up only 1% on the year, essentially equal to the return of Axon’s outperforming industrials sector at that time.

Analysts raised their price targets on Axon after the results. May price target updates tracked by MarketBeat place an average price target of around $742 on the stock. However, this implies upside in Axon shares of only around 3% compared to its May 13 closing price. So, what are the prospects for Axon going forward? Despite being a massively profitable investment over the past several years, is the company’s valuation becoming stretched?

AXON Earnings Hit on All Cylinders, Adds Strong Commentary

Axon impressed with its results both on the top and bottom lines. The company saw sales grow by 31% to nearly $604 million, surpassing expectations of 27% growth. The firm’s adjusted earnings per share (EPS) also rose by just under 23% to $1.41, over double the 10% growth rate anticipated. Axon also upped the midpoint of its revenue guidance to $2.65 billion for the full year. This was slightly higher than Wall Street had hoped.

The company also provided strong underlying news. It noted that it achieved record bookings in Q1 among international customers. International customers represent a significant growth opportunity for Axon, where it believes the total addressable market is $58 billion.

The company also noted in its earnings call that its Draft One product now has over 30,000 active users, making it its fastest-adopted software product. This product creates a transcript of user interactions recorded on the company’s body cameras. Axon says police officers spend 40% of their time writing incident reports. Draft One can significantly reduce the time it takes to write these reports through its transcription.

As of January 2024, the number of sworn police officers was down 5% from 2020 levels. Thus, there is likely a significant need for officers to be more efficient with their time, something Draft One can aid with. The Fort Collins Police Department said Draft One decreased the time officers spent writing incident reports by 67%.

Defense and Border Spending Boosts Could Be Big for Axon

Adding more good news around Axon is the fact that the United States Congress is boosting defense spending in a continuing resolution passed in March. It includes billions more in spending for the Department of Defense (DoD) and the Department of Homeland Security (DHS). This resolution funds the government through September 2025.

[content-module:Forecast|NASDAQ: AXON]

For the federal government's fiscal year 2026, starting in October 2025, President Trump wants a much larger boost in spending for DoD and DHS. The White House’s proposal calls for a 13% increase in DoD spending and a massive 65% increase in appropriations to DHS. Axon works with the U.S. Border Patrol, which is under DHS. The proposal would increase DHS spending by around $42 billion, with much of that spending going toward border security.

This funding proposal faces many challenges before it can become a reality. However, Axon’s relationship with the U.S. government could grow significantly if it passes.

Axon believes its translation technology could be greatly beneficial along the border. Built into Axon body cams, the tech translates foreign languages in real time, allowing for communication when a human translator is unavailable. Axon executive Patrick Smith shared that a Border Patrol commander asked him for this technology since officers deal with many languages at the border.

Axon Outlook: Cautious Near Term, Bullish Long Term

Despite all this great news, it is hard to argue that Axon shares are not looking stretched. The stock is now trading at a sky-high forward price-to-earnings multiple of 116. Due to this, it wouldn’t be surprising to start seeing downward pressure on Axon shares in the coming months.

However, in the long term, the bull case for Axon continues to look strong. The company regularly rolls out new innovative products with solid use cases, like the ones mentioned earlier. This, along with chances to grow U.S. government and international relationships, can lead to significant gains over time.

Where Should You Invest $1,000 Right Now?

Before you make your next trade, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis.

Our team has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and none of the big name stocks were on the list.

They believe these five stocks are the five best companies for investors to buy now...

See The Five Stocks Here

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.